Increased plasma propranolol binding in myocardial infarction.
作者信息
Routledge P A, Stargel W W, Wagner G S, Shand D G
出版信息
Br J Clin Pharmacol. 1980 Apr;9(4):438-40. doi: 10.1111/j.1365-2125.1980.tb01077.x.
Abstract
摘要
相似文献
1
Increased plasma propranolol binding in myocardial infarction.心肌梗死时血浆中普萘洛尔结合率升高。
Br J Clin Pharmacol. 1980 Apr;9(4):438-40. doi: 10.1111/j.1365-2125.1980.tb01077.x.
2
beta-blocker plasma concentrations and inflammatory disease: clinical implications.
Clin Pharmacokinet. 1982 Jul-Aug;7(4):281-4. doi: 10.2165/00003088-198207040-00001.
3
The distribution of bound propranolol between the different human serum proteins.不同人血清蛋白之间结合型普萘洛尔的分布情况。
Mol Pharmacol. 1980 Mar;17(2):187-91.
4
Relationships between propranolol plasma protein binding, glycoprotein concentration, and enzyme induction following phenobarbital administration in the dog.
Biochem Pharmacol. 1983 Sep 1;32(17):2618-20. doi: 10.1016/0006-2952(83)90033-3.
5
Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.肝素对心肌梗死急性期血清中普萘洛尔结合的影响。
Br J Clin Pharmacol. 1981 Nov;12(5):613-20. doi: 10.1111/j.1365-2125.1981.tb01279.x.
6
Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).使用基于机制的体内受体亲和力（K（B，vivo））估算，研究改变 AGP 血浆结合对大鼠中 S(-)-普萘洛尔引起的心率变化的影响。
J Pharm Sci. 2010 May;99(5):2511-20. doi: 10.1002/jps.22014.
7
Plasma drug binding: implications for anesthesiologists.
Anesth Analg. 1986 Jul;65(7):786-804.
8
Plasma protein binding of propranolol in disease states [proceedings].
Br J Clin Pharmacol. 1977 Oct;4(5):627P-628P. doi: 10.1111/j.1365-2125.1977.tb00799.x.
9
[Propranolol binding with plasma proteins and erythrocytes].
Farmakol Toksikol. 1991 Jan-Feb;54(1):55-7.
10
Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism.
Br J Clin Pharmacol. 1978 Aug;6(2):123-7. doi: 10.1111/j.1365-2125.1978.tb00836.x.
引用本文的文献
1
beta-blocker plasma concentrations and inflammatory disease: clinical implications.
Clin Pharmacokinet. 1982 Jul-Aug;7(4):281-4. doi: 10.2165/00003088-198207040-00001.
2
Therapeutic drug monitoring of antiarrhythmic agents.抗心律失常药物的治疗药物监测
Clin Pharmacokinet. 1982 Mar-Apr;7(2):125-48. doi: 10.2165/00003088-198207020-00003.
3
Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness.老年急性病患者的α1-酸性糖蛋白浓度及普萘洛尔结合情况
Br J Clin Pharmacol. 1984 Nov;18(5):806-10. doi: 10.1111/j.1365-2125.1984.tb02548.x.
4
The plasma protein binding of basic drugs.碱性药物的血浆蛋白结合情况。
Br J Clin Pharmacol. 1986 Nov;22(5):499-506. doi: 10.1111/j.1365-2125.1986.tb02927.x.
5
Free drug concentration monitoring in clinical practice. Rationale and current status.临床实践中的游离药物浓度监测。原理与现状。
Clin Pharmacokinet. 1986 Nov-Dec;11(6):450-69. doi: 10.2165/00003088-198611060-00003.
6
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).疾病引起的血浆蛋白水平变化。对药物给药方案的影响（第二部分）。
Clin Pharmacokinet. 1990 Sep;19(3):218-29. doi: 10.2165/00003088-199019030-00005.
本文引用的文献
1
Sequential changes of plasma proteins after myocardial infarction.心肌梗死后血浆蛋白的序贯变化。
Scand J Clin Lab Invest Suppl. 1972;124:117-26. doi: 10.3109/00365517209102759.
2
[Differentiated quantitative serum protein determination during myocardial infarct].
Schweiz Med Wochenschr. 1968 Nov 16;98(46):1825-9.
3
Trial of propranolol in acute myocardial infarction.普萘洛尔治疗急性心肌梗死的试验。
Br Med J. 1968 May 18;2(5602):398-400. doi: 10.1136/bmj.2.5602.398.
4
Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.人体β-肾上腺素能阻滞定量评估中的血浆普萘洛尔水平
Br Med J. 1970 Sep 26;3(5725):731-4. doi: 10.1136/bmj.3.5725.731.
5
Absence of prophylactic effect of propranolol in myocardial infarction.普萘洛尔在心肌梗死中无预防作用。
Lancet. 1966 Oct 29;2(7470):920-4. doi: 10.1016/s0140-6736(66)90533-2.
6
A controlled trial of propranolol in acute myocardial infarction.
Lancet. 1966 Oct 29;2(7470):918-20.
7
Plasma binding and the affinity of propranolol for a beta receptor in man.
Clin Pharmacol Ther. 1976 Aug;20(2):152-7. doi: 10.1002/cpt1976202152.
8
Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling.由于使用留置肝素化插管（肝素锁）进行采样导致药物结合改变。
Clin Pharmacol Ther. 1979 Jan;25(1):103-7. doi: 10.1002/cpt1979251103.
9
Reduction of enzyme levels by propranolol after acute myocardial infarction.急性心肌梗死后普萘洛尔降低酶水平。
Circulation. 1978 Jun;57(6):1091-5. doi: 10.1161/01.cir.57.6.1091.
10
Variable binding of propranolol in human serum.
Biochem Pharmacol. 1979 Mar 15;28(6):905-11. doi: 10.1016/0006-2952(79)90374-5.
Zotero 插件